Benchmark Holdings Regulatory News (BMK)

Information within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulations (EU) No. 596/2014. 

Benchmark Holdings

("Benchmark" or the "Company")

BMK08+CleanTreatÒ Update

First customer agreements signed

Benchmark Holdings is pleased to announce that it has signed its first customer agreements for the delivery of its novel water purification system, CleanTreatÒ. The agreements secure customer access to one of Benchmark's CleanTreatÒ units which will be deployed in conjunction with the new sea lice treatment BMK08. The agreements remain subject to the regulatory process to obtain a Marketing Authorisation in Norway for BMK08.

BMK08 and CleanTreatÒ is a transformational solution addressing the biggest biological challenge in salmon farming. Benchmark's breakthrough solution is the result of almost a decade of research and development conducted by leading scientists and involving a rigorous trial programme as well as substantial capital investment.

CleanTreat is a closed water purification system which captures the medicine from the treatment water avoiding the discharge of medicines into the ocean. It has the potential to be used in conjunction with other medicines in aquaculture thus addressing an important environmental concern.

Trond Williksen, CEO, commented:

"I am very pleased to be signing our first customer agreements for Benchmark's transformational solution. Our solution addresses the biggest challenge facing the salmon industry today in a sustainable way both in terms of animal welfare as well as environmental impact.

BMK08 and CleanTreat are testament to Benchmark's commitment to its mission of driving sustainability in aquaculture."

Enquiries: